ArticleChemical science2026
TeLLAgent: a dual-agent framework for reliable scientific discovery with tool-enhanced LLMs.
Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Large language model agents hold immense promise for automating scientific discovery, yet their real-world application is hindered by an inability to reliably orchestrate tools and execute complex, multi-step plans without encountering hallucinations or logical inconsistencies. Here, we present TeLLAgent, a novel supervisor-executor dual-agent framework that explicitly separates strategic reasoning from precise tool operation to overcome these limitations. The global planning agent, powered by DeepSeek-R1, performs iterative chain-of-thought reasoning to decompose problems and formulate dynamic plans. The local execution agent, leveraging DeepSeek-V3.1, then accurately invokes a curated suite of 30 specialized tools. A critical self-correction loop, mediated by the Model Context Protocol, allows the system to "rethink" and "recover" from failures, significantly enhancing robustness. When rigorously benchmarked on a suite of complex tool-calling tasks, TeLLAgent significantly outperformed GPT-5 and existing agent frameworks, achieving higher success rates in multi-step planning and demonstrating superior scaling with task complexity. Furthermore, TeLLAgent drastically reduced factual hallucinations in knowledge retrieval, as validated by both human experts and LLM judges, underscoring its enhanced reliability. We ultimately demonstrate the power of this approach by deploying TeLLAgent for autonomous discovery in the demanding domain of organic solar cell materials. From a single natural language query, it executed an end-to-end workflow, from molecular design and property prediction to the identification of a high-performance quasi-macromolecular acceptor. This AI-designed molecule was subsequently synthesized and validated, achieving a power conversion efficiency of 16.44%. TeLLAgent establishes a new paradigm for building reliable, autonomous AI systems, proving its potential to accelerate scientific discovery in materials science, drug discovery, and beyond.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.